Status:
COMPLETED
Comparison of Intracardiac Echocardiography and Transesophageal Echocardiography
Lead Sponsor:
Elad Anter
Collaborating Sponsors:
Biosense Webster, Inc.
Conditions:
Atrial Fibrillation
Atrial Flutter
Eligibility:
All Genders
18+ years
Brief Summary
The presence of intracardiac thrombi and their propensity for systemic embolism is a major concern in patients with atrial fibrillation (AF) and atrial flutter (AFL) undergoing cardioversion and ablat...
Detailed Description
Transesophageal echocardiography (TEE) is the clinical standard for diagnosis of left atrial appendage (LAA) and right atrial appendage (RAA) thrombi before cardioversion or instrumentation of the lef...
Eligibility Criteria
Inclusion
- Patients able to understand and critically review the informed consent.
- Patients presenting for an AF and/or AFL ablation procedure who have clinical indication for TEE and ICE.
Exclusion
- Patients in whom placement of an ICE catheter for adequate atrial visualization is technically not feasible.
- Patients requiring urgent cardioversion.
- Patients with a contraindication for TEE
- Inability to give informed consent.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT02213666
Start Date
January 1 2012
End Date
May 1 2014
Last Update
May 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215